Alzheimer's disease (AD) and related dementias (ADRD) collectively affect a significant
portion of the aging population worldwide. The pathological progression of AD involves not …

Currently, approaches to personalized medicine are actively developing. For example, the
use of platelet-rich plasma (PRP) is actively growing every year. As a result of activation …

Background Leukocyte-platelet aggregates comprise a pathogenic link between hemostasis
and immunity, but the prerequisites and mechanisms of their formation remain not …

Simple Summary Hepatocellular carcinoma (HCC) associated with portal vein thrombosis
(PVT) represents an advanced stage of the tumor, with a subsequently poor prognosis and …

Kawasaki disease, a systemic vasculitis that affects young children and can result in
coronary artery aneurysms, is the leading cause of acquired heart disease among children …

Ulcerative colitis (UC) is a refractory, chronic inflammatory bowel disease of unknown
etiology. Although platelets are activated in UC, their relevance in pathophysiology remains …

Background Inflammation serves an essential function in the occurrence and progression of
heart failure (HF), especially in the early stage. Lonicerae japonicae Flos (LJF), Angelicae …

Objective Despite amyloid deposition as a hallmark of hereditary transthyretin amyloidosis
(ATTRv) with polyneuropathy, this pathology could not completely account for nerve …

Targeting microRNAs is a promising therapeutic approach to control thrombosis in patients
with both infectious and noninfectious inflammatory diseases. Future research efforts should …

Thromboinflammation, the interplay between thrombosis and inflammation, is a significant
pathway that drives cardiovascular and autoimmune diseases, as well as COVID-19. SARS …